Skip to main content
Signal8
Launch Terminal
Markus Richard profile photo

Richard Markus

CIK: 0002056093

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Arcus Biosciences, Inc. logo
RCUS

Arcus Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Arcus Biosciences, Inc. logo
    RCUS

    Arcus Biosciences, Inc.

    Jan 23, 2026
    Award(A)
    Direct
    24K shares-
  • Arcus Biosciences, Inc. logo
    RCUS

    Arcus Biosciences, Inc.

    Dec 17, 2025
    Sale(S)
    Direct
    4.5K shares at avg. $22.16$100K
  • Arcus Biosciences, Inc. logo
    RCUS

    Arcus Biosciences, Inc.

    Dec 16, 2025
    Sale(S)
    Direct
    5.1K shares at avg. $21.88$111K
  • Arcus Biosciences, Inc. logo
    RCUS

    Arcus Biosciences, Inc.

    Feb 10, 2025
    Award(A)
    Direct
    75.2K shares-

1-4 of 4

About Markus Richard

Markus Richard (SEC CIK 0002056093) files insider reports with the SEC as Chief Medical Officer of Arcus Biosciences, Inc. (RCUS).

Signal8 holds 4 ownership filings by Markus Richard (1 Form 3, 3 Form 4), filed between Feb 11, 2025 and Jan 26, 2026. Those filings report 4 transactions, from Feb 10, 2025 to Jan 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Markus Richard's filings is in HAYWARD, CA.

Recent filings by Markus Richard

  • Jan 23, 2026: Grant or award of RCUS shares (Form 4, code A).
  • Dec 17, 2025: Open-market sale of RCUS shares (Form 4, code S).
  • Dec 16, 2025: Open-market sale of RCUS shares (Form 4, code S).
  • Feb 10, 2025: Grant or award of RCUS shares (Form 4, code A).

Other insiders filing for Arcus Biosciences, Inc. (RCUS)

How to read Form 4 transaction codes